
    
      post heart transplantation patients treated with everolimus will be screened for vitamin D
      levels. Patients defined as deficient will be treated with vitamin D with close and intensive
      monitoring everolimus levels, adjusting oral daily dose to maintain therapeutic levels.
    
  